Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$40,057,955
+$28,922,955 QoQ
Shares Held
300,600
+200.6% QoQ
Ownership
0.345%
of shares outstanding
% of Portfolio
15.42%
of 13F equity value
Holder Rank
#42
of 301 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$3,957,822
CallShares
29,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kite Lake Capital Management (UK) LLP holds $40,057,955 across 1 Biotechnology name. ABVX ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
This page
|
300,600 | $40,057,955 |
All Filings in ABVX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,957,822 | 29,700 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $40,057,955 | 300,600 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,307,095 | 29,700 | Call | Sole | 2026-05-15 | |
| 2026-03-31 | $11,135,000 | 100,000 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||